Concept:
The management of regional lymphatics is the most critical prognostic factor in penile carcinoma. Dynamic Sentinel Lymph Node Biopsy (SLNB) is a minimally invasive staging tool with specific strict indications.
Explanation:
• Penile cancer spreads primarily via the lymphatic system to the superficial, and subsequently deep, inguinal lymph nodes.
• If a patient presents with clinically palpable and suspicious inguinal lymph nodes (Option C), the standard protocol is to undergo an ultrasound-guided Fine Needle Aspiration Cytology (FNAC).
• If the FNAC is positive (Option B), the presence of macroscopic disease is confirmed. The required treatment is a formal therapeutic Inguinal Lymph Node Dissection (ILND). Performing an SLNB here is absolutely contraindicated because large tumor deposits can block normal lymphatic channels, rerouting the radioactive tracer and causing a false-negative result.
• However, in patients who have clinically negative groins (impalpable nodes, cN0), up to 20-25% will harbor occult microscopic metastases depending on the primary tumor grade and stage (e.g., T1G2 or higher).
• To avoid the high morbidity (lymphedema, wound necrosis) of a prophylactic radical inguinal dissection in all these patients, a dynamic SLNB utilizing a radioactive tracer (Tc-99m) and patent blue dye is performed.
• This precisely identifies the first draining node; if it is negative, the patient is safely spared a morbid formal dissection.
Final Answer:
Dynamic SLNB is strictly indicated as a staging procedure for patients with clinically impalpable inguinal lymph nodes (cN0) who are at risk for occult metastasis.